Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease
Clinical trial NCT01527916 · COMPLETED
Trial details
- NCT number
- NCT01527916
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2013-11-01
- Enrollment
- 438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.